Literature DB >> 6661370

The clinical pharmacology of chlorambucil and prednimustine.

D R Newell, A H Calvert, K R Harrap, T J McElwain.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661370      PMCID: PMC1428359          DOI: 10.1111/j.1365-2125.1983.tb02264.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  9 in total

1.  Non-Hodgkin's lymphomas. II. Single agent chemotherapy.

Authors:  S E Jones; S A Rosenberg; H S Kaplan; M E Kadin; R F Dorfman
Journal:  Cancer       Date:  1972-07       Impact factor: 6.860

2.  On the clinical pharmacology of prednimustine.

Authors:  G Plym Forshell; P O Gunnarsson; J Liljekvist
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

3.  Preliminary clinical and absorption studies with prednimustine in patients with mammary carcinoma.

Authors:  I Könyves; B Nordenskjöld; G P Forshell; A de Schryver; H Westerberg-Larsson
Journal:  Eur J Cancer       Date:  1975-12       Impact factor: 9.162

4.  Pharmacokinetics of chlorambucil in man after administration of the free drug and its prednisolone ester (prednimustine, Leo 1031).

Authors:  H Ehrsson; I Wallin; S O Nilsson; B Johansson
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

5.  Pharmacokinetics and metabolism of chlorambucil in patients with malignant disease.

Authors:  A McLean; R L Woods; D Catovsky; P Farmer
Journal:  Cancer Treat Rev       Date:  1979-06       Impact factor: 12.111

6.  Comparative pharmacokinetics of chlorambucil and melphalan in man.

Authors:  D S Alberts; S Y Chang; H S Chen; B J Larcom; T L Evans
Journal:  Recent Results Cancer Res       Date:  1980

7.  The pharmacokinetics of prednimustine and chlorambucil in the rat.

Authors:  D R Newell; C R Shepherd; K R Harrap
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

8.  Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemia.

Authors:  A Sawitsky; K R Rai; O Glidewell; R T Silver
Journal:  Blood       Date:  1977-12       Impact factor: 22.113

9.  Studies on the pharmacokinetics of chlorambucil and prednimustine in man.

Authors:  D R Newell; A H Calvert; K R Harrap; T J McElwain
Journal:  Br J Clin Pharmacol       Date:  1983-02       Impact factor: 4.335

  9 in total
  1 in total

1.  Cellular kinetics of prednimustine versus chlorambucil plus prednisolone in vitro.

Authors:  E Musch; M Malek; J Peter-Katalinic; H Egge; H Rink; B Lathan; E Riedel
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.